Your Poop Type
Take This 60 Second Quiz To Determine How Healthy Is Your Poop
Do you use the inhalers by GlaxoSmithKline, LLC, i.e. GSK? Then you must have heard the news. And for those of you who don’t know there is a defect in these inhalers.
According to an FDA statement Inhalers by GSK, GlaxoSmithKline, LLC, recalled due to a defective delivery system. We are talking about nearly 600,000 Asthma Inhalers. There is a nationwide distribution of the inhalers.
In fact, GlaxoSmithKline made a recall of the product voluntarily on April 4, reported by the Asthma and Allergy Foundation of America’s website.
Three impacted lots of Ventolin HFA 200D Inhalers with lot numbers of 6ZP9944, 6ZP9848, 6ZP0003.
Although the defects are not dangerous to them, the users can return them. The reason why they returned them is that the inhalers didn’t have leak rates. According to GSK as a result of the issue, they don’t expect to have an impact on the supply to Ventolin HFA 200D inhaler.
The model of inhalers that had a defect is “Ventolin HFA”, 200 metered inhalations, 90 mcg per actuation, net weight 18 g inhalers, RX only.
Statement by the Company
According to the company, they commit to supply products that are of high quality. And that their main goal is to have satisfied customers. They regret if the recall caused any inconvenience.
Last week, there was a huge recall of EpiPens after some had defects- to be more accurate 13 lots of products. The EpiPens are known for the injection of epinephrine that is a life-saving function once inserted in the body. Especially, for people that have allergic reactions that are extreme.
On Friday there was a press release about that. And according to the Food and Drug Administration, the recall was made due to the fact that these devices have a defective part. That may cause failure to the devices to activate.
For more information watch the video:
Source Pix11 | Pix 11; Image Source Knoe